Table 1.
Clinical Laboratory findings.
| Measure | Reference Range | Emergency Department | Hospital Day 1 | Hospital Day 2 | Hospital Day 3 | Hospital Day 4 | Hospital Day 5 | Hospital Day 6 | Hospital Day 7 |
|---|---|---|---|---|---|---|---|---|---|
| Cardiac biomarkers: | |||||||||
| hs-Troponin T (ng/L) | 0–14 | 289* | 515* | 413* | 457* | – | 19.7* | – | 12.8 |
| CK-MB (µg/L) | <4.9 | – | 27.4* | 21.0* | 5.2* | – | 1.7 | – | 1.6 |
| NT-pro-BNP (ng/L) | 0–210 | – | – | – | – | – | – | – | 20 |
| Inflammatory biomarkers: | |||||||||
| C-reactive protein (mg/dL) | <0.5 | 2.9* | – | 2.1* | – | – | – | – | 0.4 |
| ESR (mm/h) | 2–10 | – | – | – | – | – | – | – | 16* |
| Ferritin (ng/mL) | 30–400 | – | – | 370 | – | – | – | – | 457* |
| Whole blood count: | |||||||||
| White-cell count (per µl) | 4,000–10,000 | 5,500 | – | 7,700 | 5,870 | – | – | – | 7,120 |
| Lymphocytes (absolute count per µL) | 900–4,000 | 1,330 | – | 1,460 | 1,830 | – | – | – | 1,760 |
| Lymphocytes (%) | 20.0–50.0 | 24.2 | – | 18.8 | 31.2 | – | – | – | 24.7 |
| Eosinophilis (absolute count per µL) | 0–450 | 60 | – | 80 | 120 | – | – | – | 150 |
| Eosinophilis (%) | 0–4.5 | 1.1 | – | 1.0 | 2.0 | – | – | – | 2.1 |
| Hemoglobin (g/dl) | 14.0–18.0 | 16.6 | – | 15.2 | 15.7 | – | – | – | 15.2 |
| Hematocrit (%) | 32.0–52.0 | 47.9 | – | 45.3 | 47.4 | – | – | – | 44.5 |
| Platelet count (per µl) | 140,000–440,000 | 249,000 | – | 207,000 | 237,000 | – | – | – | 288,000 |
| Hepatic biomarkers: | |||||||||
| ALT (U/L) | 3–45 | 35 | – | 33 | – | – | – | – | 39 |
| GGT (U/L) | 2–50 | – | – | 41 | – | – | – | – | 35 |
| Bilirubin (mg/dL) | 0.25–1 | 0.34 | – | 0.86 | – | – | – | – | 0.57 |
| Proteins (g/dL) | 6.4–8.5 | – | – | 6.5 | – | – | – | – | 6.5 |
| Total cholesterol (mg/dL) | – | – | 203 | – | – | – | – | 154 | |
| Triglycerides (mg/dL) | – | – | 126 | – | – | – | – | 82 | |
| INR | 0.86–1.13 | 0.98 | – | – | – | – | – | – | 0.98 |
| Renal function: | |||||||||
| Creatinine (mg/dL) † | 0.67–1.17 | 0.90 | – | 0.82 | 0.84 | – | – | – | 0.99 |
| Others: | |||||||||
| LDH (U/L) | 135–225 | – | – | – | – | – | – | – | 186 |
| CK (U/L) | 30–200 | 235 | 356* | – | – | – | – | – | 78 |
| Amilase (U/L) | 28–100 | – | – | 43 | – | – | – | – | 53 |
| Glucose (mg/dL) | 70–100 | 99 | – | 90 | – | – | – | – | 85 |
| Sodium (mmol/L) | 132–143 | 140 | – | 141 | 142 | – | – | – | 139 |
| Potassium (mmol/L) | 3.4–5.2 | 3.78 | – | 4.12 | 4.29 | – | – | – | 5.1 |
| D-dimer (µg/mL) | 0.0–0.57 | – | – | – | – | – | – | – | 1.99* |
| TSH (µg/mL) | 0.27–4.20 | – | – | – | – | – | – | – | 0.30 |
* The value in the patient was above normal.
† To convert the values for creatinine to micromoles per liter, multiply by 88.4.
ESR indicates erythrocyte sedimentation rate.
Furthermore, anti-ANA, -ENA and -nDNA tests were negative, rheumatoid factor, and complement C3 and C4 levels were within the normal ranges.